Consistency of Analytical Performance Characteristics and Other Observed Trends from the Validation of comprehensive Genomic Profiling LDTs by Diverse Laboratories
Get access
Client Publications
On October 15, 2024 | By The Velsera Clinical and Compliance Team
A Utility Tool for Personalised Medicine
Read more
Blog
On October 10, 2024 | By Cates Mallaney
A Winning Methodology: Key Criteria for Success in Launching an NGS assay
Read more
News
On October 8, 2024 | By The Velsera Clinical and Compliance Team
Velsera and Diagnostica Longwood Partner to Revolutionize Access to Precision Genomics for Patients in Spain and Portugal
Read more
Video
On October 3, 2024 | By The Velsera Clinical and Compliance Team
Optimizing RCM with 2024 CPT Code Updates
Read more
Video
On October 2, 2024 | By The Velsera Clinical and Compliance Team
The Variant Interpretation for Cancer Consortium (VICC) – FDA LDT Discussion
Read more
News
On September 16, 2024 | By The Velsera Clinical and Compliance Team
Velsera Technology Paves the Way for Advanced Cancer Diagnostics with FDA Approval of Illumina TruSight™ Oncology Comprehensive IVD
Read more
Blog
On September 12, 2024 | By Liam Scott
A Story of Support: Our Innovation Improves Your Results
Read more
Video
On September 10, 2024 | By The Velsera Clinical and Compliance Team
Tackling Complexity in Oncology Biomarker Interpretation with CGW Plus
Read more